Inhibition of Angiotensin 1-Converting Enzyme by Phosphopeptides in Proteolitic Hydrolysates Derived from Oyster, Crassostrea gigas by Tamari Masato & Kanda Hiroko
Bulletin of Faculty of Education, Nagasaki University: Natural Science No.6!' PP. 41 ~51 0999. 6)
Inhibition of Angiotensin I-Converting Enzyme
by Phosphopeptides in Proteolytic Hydrolysates
Derived from Oyster, Crassostrea gigas.
Masato T AMARI and Hiroko KANDA
Department of Food and Nutrition, Faculty of Education,
Nagasaki University, Nagasaki 852-8521, Japan
(Received March 15, 1999)
ABSTRACT
Hydrolysates which inhibit the angiotensin I-converting enzyme (ACE) were pre-
pared from oyster with three kinds of proteases.
The inhibitory activity of ACE detected in the hydrolysates by three kinds of proteases
of oyster was fractionated into two major phosphopeptides fractions of P-I and P-2 in
peptic hydrolysates, T~1 and T--2 in tryptic hydrolysates, C-I and C-2 in chymotryptic
hydrolysates by gel filtration chromatography on Sephadex G-50, respectively.
The inhibition of ACE of the six kinds of phosphopeptides fractions (P--l, P-2,
T-l, T-2, C-l and C-2) was investigated in vitro.
The IC50 values of P-l, P-2, T-l, T-2, C-l, and C-2 of phosphopeptides for ACE
were 0.3, 2.9, 2.7, 2.6, 1.5 and 1. 4mg protein/ml, respectively.
The pepsin treated fraction P-I had most inhibition activity and showed O. 3mg pro-
tein/ml inhibition against ACE at IC50 value.
The phosphono-compounds was found in the phosphopeptides fractions of hydroly-
sates with three kinds of protease.
It has been demonstrated that the P-l, P-2, T-l, T-2, C-l and C-2 contained about
79.13%, 79.19%, 11. 07%, 4.71%, 15.26% and 4.49% as phosphonate-phosphorus of
total phosphorus.
The amino acid compositions of the phosphopeptides fractions (P-l, P-2, T-I,
T-2, C-l and C-2) were characterized by relatively high percentage for glutamic acid,
aspartic acid, alanine, lysine and threonine.
INTRODUCTION
Protein from natural resources are important for supplying nutrient and energy.
Recently, it has become apparent that they also have many functions relating to physio-
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logical regulation I , 2 ). A number of functional peptides derived from milk, soybeen and
fish have been found, which may serve to promote Ca absorption 3 ), lowering of blood pres-
sure 2, 4 ~ 9), regulation of cholesterol in serum10) and other benefitsl!).
The ACE inhibitory abilities of foods have recently been investigatedI2) • ACE (EC.
3 , 4 ,15, 1) play an important physiological role inregulating blood pressure, ACE'
catalyzes the conversion of inactive angiotensin 1 to a potent vasoconstrictor angiotensin
II 13, 14).
Our interest has been focused on the preparation and isolation of phosphopeptides
from natural resources that are involved in blood pressure regulation. In previous
papersI5~17), phosphoproteins and phosphopeptides that inhibited the ACE were isolated
from edible shellfish.
Many investigators have tried to prepare and isolate the ACE Inhibitory peptides.
In this report, we investigate the effectiveness of three kinds of proteolytic hydrolysates
as a physiologically functional food and attempt to isolate the ACE inhibitory phos-
phopeptides from the three kinds of proteolytic hydrolysates of Oyster.
MATERIALS AND METHODS
Materials: Edible Oyster, Crassostrea gigas was purchased on the localmarket. Sephadex
G-50 was a product of Pharmacia. Proteolytic enzymes (pepsin, trypsin, chymotrypsin)
was obtained from Boehringer Co. ACE from rabbit lung acetone powder were obtained
from Sigma Chemical Co. (U. S. A.).
Hippuryl-L-histidyl-leucine(HHL)as a substrate was obtained from the Peptide In-
stitute(Osaka, Japan). All other reagents were obtained from Nacalai Tesque(Kyoto,
Japan) .
Assay of ACE inhibitory activity: The activity of ACE inhibition was assayed by the
method of Yamamoto et. aIlS).
For each assay, lOOp 1of ACE inhibitor and 50p 1of Hip-His-Leu(2. 5mM in a borate
buffer containing 200mM NaCl at pH 8. 3) were incubated with 100pI of 2. 5mu/ml of
ACE at 37°C for 30min. The reaction was stopped by adding 250p 1of IN HCl, and 1. 5ml
of ethyl acetate was then added to the mixture, and the mixture was shaked for 30sec. The
mixture was centrifuged at 2500 rpm for 1Omin., and 1. 25ml from the supernatant was
transfered to test tube, and then heated at 120°C for 30min., O. 5ml of 1M NaCI was then
added to the dried material, and the solution was shaked for 30sec., and the absorbance of
the yielded hippuric acid at 228nm was measured with a Hitachi 101 spectrophotometer.
The ACE inhibitor concentration required to inhibit 50% of the ACE activity is de-
fined as the IC50 value.
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Isolation and preparation of ACE inhibitors from proteolytic hydrolysates :
CD Hydrolysis by pepsin:
The freeze-dried material (26.4 g) of Oyster, Crassostrea gigas was extracted with
550ml of O. OIM Tris-HCl bufferCpH 8.0) by an efficient magnetic stirrer in a 1000ml
beaker at room temperature for 2hrs. The extracts were centrifuged at 3000rpm for l5min.
The supernatant was freeze-dried and approximately extract l5g was obtained. The
freeze-dried extract (4. 9 g) was dissolved in 100ml of HCl-KCl buffer (pH 2.0), and
then 100mg of pepsin was added to the mixture, and the mixture incubated at 3TC for
24hrs. After proteolysis, the solution was then heated for l5min. in a boiling-water bath.
After the precipitate had been removed by centrifugation at 3000rpm for l5min, the
supernatant was then dialyzed for 24hrs. to remove inorganic salts. Dialyzed solution was
centrifuged again, and supernatant was freeze-dried.
® Hydrolysis by trypsin and chymotrypsin:
The freeze-dried extract(4. 9 g) was dissolved in 100mi of O. OIM Tris-HCI
bufferCpH 8.0), and then 100mg of trypsin or chymotrypsin was added to mixture, and
the mixture incubated at 37 DC for 24hrs. After proteolysis, the solution was then heated for
l5min. in a boiling-water bath.
After the precipitate had been removed by centrifugation at 3000rpm for 15min., the
supernatant was then dialyzed for 24hrs. to remove inorganic salts. Dialyzed solution was
centrifuged again, and supernatant was freezec-dried.
Fractionation of inhibitor by column chromatography:
The freeze-dried hydrolysate of pepsin, trypsin and chymotrypsin was dissolved in
l5ml of O. OIM Tris--HCl buffer and then applied to a 2.5 x 40cm column of Sephadex
G-50 (prewashed with O. OIM Tris-HCI buffer). The column was eluted with 500ml of
O. OIM Tris-HCI buffer. The eluate was collected in 10mi fractions,while monitoring the
absorbance at 280nm for peptides and at 820nm for total phosphorus. (Peptic, tryptic and
chymotryptic fractions were denoted as P-l, P-2, T--l, T--2, C-l and C-2, respectively).
Each fraction was collected, and determined the phosphonate phosphorus, amino acid
and ACE inhibitory activity.
Quantitative analysis:
Total phosphorus was estimated by the method of Chen eLaP9l. Phos-
phonate-phosphorus was estimated by the method of Tamari et. aPO) . Amino acid ana-
lyses were carried out with a ]TC-200A amino acid analyzer. The sample for amino acid
analyses was hydrolyzed in 6N HCI at 110 DC for 24hrs. The nitrogen and protein were
analyzed in the usual way (% protein = % N x 6. 25) .
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RESULTS
Fig. 1 showed the Sephadex G-50 column chromatogram of the peptic hydrolysates
of Oyster, Crassostrea gigas. The experimental details are described in the text. The entire
effluent was collected in tubes on a fraction collector for quantitative analysis of the
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Fig. 1. Chromatographic Profile of Phosphopeptides Eluted by Sephadex G-50 Column Chro-
matography from the Hydrolysates Obtained by Peptic Hydrolysis of Oyster, Crassostrea
gigas.
The experimental details are described in the text.
• -. indicate total-phosphorus and • -. indicate phosphopeptides at 280nm in the col-
lected fractions. Po-land P-2 represent combined fractions 6 ~IO and fractions 18~24,
respectively.
Two phosphorus-containing peaks and two peptides peaks were eluted from the
column in the case of peptic hydrolysates. The first peak and second peak designated as
P-l and P-2, respectively.
The maximum total-phosphorus content was observed in fraction No.7 in the case of
P-l, and in fraction No.19 in the case of P-2 as shown in the Fig. 1 .
In addition, the maximum absorption at 280nm was observed in fraction No.7 in the
case of P-l, and in fraction No.2l in the case of P-2. Fraction No.6 -------10 of the P-l and
fraction No.18-------24 of the P-2 were pooled, and analysed for phosphonate-phos-
phorus CC-P) , amino acids and ACE inhibitory activity.
Fig. 2 shows the Sephadex G-50 column chromatogram of the tryptic hydrolysates of
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Oyster, Crassostrea gigas. The experimental details are described in the text.
The entire effluent was collected in tubes on a fraction collector for quantitative
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Fig. 2. Chromatographic Profile of Phosphopeptides Eluted by Sephadex G-50 Column Chro-
matography from the Hydro1ysates Obtained by Tryptic Hydrolysis of Oyster, Crassostrea
gigas.
The experimental details are described in the text.
• -. indicate total-phosphorus and.-. indicate phosphopeptides at 280nm in the col-
lected fractions. T 1 and T-2 represent combined fractions 5 ~ 10 and fractions 15~26,
respectively.
Two phosphorus-containing peaks and two peptides peaks were eluted from the
column in the case of tryptic hydrolysates.
The first peak and second peak designated as T-l and T-2, respectively.
The maximum total-phosphorus content was observed in fraction No.8 in the case of
T -1, and in fraction No.19 in the case of T - 2 as shown in the Fig. 2 .
In addition, the maximum absorption at 280nm was observed in fraction No.7 in the
case of T-1, and in fraction No.19 in the case of T-2. Fraction No. 5 ~IO of the T-I and
fraction No.15~26 of the T-2 were pooled, and analysed for phosphonate-phosphorus,
amino acids and ACE inhibitory activity.
Fig. 3 shows the Sephadex G-50 column chromatogram of the chymotryptic
hydrolysates of Oyster, Crassostrea gigas.
The experimental details are described in the text.
The entire effluent was collected in tubes on a fraction collector for quantitative
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Fig. 3. Chromatographic Profile of Phosphopeptides Eluted by Sephadex G~50 Column Chro-
matography from the Hydrolysates Obtained by Chymotryptic Hydrolysis of Oyster, Cras-
sostrea gigas.
The experimental details are described in the text.
• - .indicate total~phosphorusand • -. indicate phosphopeptides at 280nm in the col-
lected fractions. (-1 and (-2 represent combined fractions 6 ~lO and fractions l6~27,
respectively.
analysis of the total phosphorus and for qualitative analysis of the phosphopeptides at
280nm.
Two phosphorus-containing peaks and two peptides peaks were eluted from the
column in the case of chymotryptic hydrolysates.
The first peak and second peak designated as C-l and C-2, respectively. The max-
imum total-phosphorus contents were observed in fraction No.7 in the case of C-1, and
in fraction No.20 in the case of C-2 as shown in the Fig. 3 .
In addition, the maximum absorption at 280nm was observed in fraction No.7 in the
case of C-l, and in fraction No.20 in the case of C-2. Fraction No.6 -----10 of the C-1, and
fraction No.l6-----27 of the C-2 were pooled, and analysed for phosphonate-phosphorus,
amino acid and ACE inhibitory activity.
In Table 1 is reported the phosphorus contents of the P-1, P-2, T-1, T-2, C-l and
C-2 from the proteolytic hydrolysates of the Oyster, Crassostrea gigas.
The total-phosphorus content in the P-1, P-2, T-1, T-2, C-l and C-2 fractions
were 5.08, 714.54, 23.13, 390.71, 12.38 and 261. 72/1 g per ml of the peaks of the
Crassostrea gigas, respectively.
The amounts of phosphonate-phosphorus(C-P) in the P-1, P-2, T-1, T-2, C-l and
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Table 1 . Phosphorus Contents of the P 1, P2, T 1, T·2, C -1 and C-2 from the
Proteolytic Hydro1ysates of the Oyster, Crassostrea gigas.
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Fraction T -P (fl g ImD CP(fl g ImD C-P I TP(%)
PI ;i. 08 4.02 ( 0.67) 79.13
P-2 714.54 565.86 (93.61 ) 79.19
T1 23.13 2.56 ( 0.24) 11. 07
T2 90.71 18.41 ( 3.(5) 4.71
C1 12.38 1. 89 ( 0.31) 15.26
C2 261. 72 11.76 ( 1.95) 4.49
Abbreviations used are:
C -P, Phosphonate-phosphorus ; T-P, Total phosphorus ;
( ), as % of Total C P
Table 2. Amino Acid Composition in the Acid Hydro1ysates of Phosphopeptides in the P 1,
P·2, T-l, T-2, C 1 and C-2 Fractions Eluted by Sephadex G50 Column
Chromatography of the Three Different Enzymatic Hydro1ysates of Oyster,
Crassostrea gigas.
Amino P-l P2 T1 T 2 C 1 C-2Acid
Asp 249.6 433.8 269.3 954.1 136.4 986.4
Thr 91. 8 441. 2 218. 1 426.2 130.3 487.1
Ser 102.6 293.5 166.9 459.9 87.1 508.2
G1u 448.6 442. 1 269.1 1, 729. 4 115. 1 1, 573. 4
Gly 160.2 286.9 149.1 731. 1 80.0 709.2
Ala 174.5 293.2 131. 4 608.4 86.0 601.2
Cys 7.3 100.0 32.9 19.7 8.3 0.0
Val 81. 2 163.9 119. 1 445.6 79.8 464.0
Met 38.3 51. 5 24.3 21. 1 8.8 0.0
I leu 68.4 102. 1 82.4 378.3 41. 7 379.8
Leu 144.0 129.0 127.1 639.7 68.0 658.3
Tyr 76.3 446.6 218.1 233.5 123.9 171. 9
Phe 88.0 294.7 150.0 323.9 74.8 364.1
His 52.2 232.0 122.6 334.1 50.2 381.1
Lys 137.4 679.3 119.1 977.2 71. 9 911. 7
Arg 123.6 200.0 55.0 396. 7 32.0 601.9
Pro 140.0 393.4 143.3 724.3 73. 7 812.5
2-AEP 16. 1 2,263.4 10.2 73.6 7.6 47.0
Total 2,200.0 7,246.6 2,407.9 9,477.1 1, 275. 5 9,657.8
• Values are expressed as flg/mg Nitrogen .
• Abbreviations used are: 2- AEP, 2- aminoethy1phosphonic acid.
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C-2 were 4.02, 565.86, 2.56, 18.41, 1. 89 and 11. 76p g per ml of the peaks.
In addition, about 79, 79, 11, 4, 15 and 4 % of the total-phosphorus in the P-1,
P-2, T-1, T-2, C-l and C-2 fractions was found to be phosphonate, which was primarily
2 - aminoethylphosphonic acid.
The P-2 fraction contained 93.6% of the phosphonate, and the amount of phos-
phonate in the P-2 fraction was 141, 221, 31, 299 and 48 times higher than those in the
P-1, in the T-l, in the T-2, in the C-I and in the C-2 fractions, respectively.
Table 2 summarises the amino acid composition of the P-1, P-2, T-1, T-2, C-l and
C-2 fractions obtained under three different proteolytic hydrolysis.
Of note in P-1, P-2, T-1, T-2, C-l and C-2 peaks is the very high acidic amino
acids (Asp and Glu) , Gly, Ala, Leu, Lys and Pro content, and the presence of unique
amino acid, 2 - aminoethylphosphonic acid.
In P-2 phosphopeptide, the 2 - AEP content was high, when compared to P-2, other
peaks(P-1, T-1, T-2, C-l and C-2) had a low 2 - AEP.
Cheung et.al.21) and Matsui et.al. 6) have reported that it was essential for strong and
competitive ACE inhibition that a peptide had aromatic amino acid residues at the
C-terminaICi. e., Try. Tyr. Pro.), and hydrophobic or basic ones at the N-terminal.
Table 3 . Angiotensin Converting Enzyme Inhibitory Activity of the P-l, P-2,
T-l, T-2, c--l and C-2 Phosphopeptides Eluted by Sephadex G--50
Column Chromatography of the Hydrolysates Obtained by Various
Enzymatic Hydrolysis of Oyster, Crassostrea gigas





c--l 0.85 1. 53
C-2 2.30 1. 47
Table 3 shows angiotensin converting enzyme inhibitory activity of the P-1, P-2,
T-1, T-2, C-l and C-2 phosphopeptides eluted by Sephadex G-50 column chromatography
of the hydrolysates obtained by various enzymatic hydrolysis of oyster, Crassostrea gigas.
The ICso values for P-1, P-2, T-1, T-2, C-I and C-2 were 0.3, 2.9, 2.7, 2.6,
I . 5 and 1. 5 mg protein/ml, respectively.
The pepsin treated fraction P-l had most inhibition activity and showed 0.3 mg
protein/ml inhibition against ACE at ICso value, and the ICso value in the P-l fraction was
9. 6, 9. 0, 8. 7, 5. 0 and 4. 7 times higher than those in the P-2, in the T-1, in the T- 2, in
the C-l and in the C-2 fractions, respectively.
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Our interest has been focused on the preparation and isolation of phosphopeptides
from natural resources that are involved in blood pressure regulation. To date, there is still
no report on the ACE inhibition activity of the phosphopeptides and phosphonopeptides in
nature. This report describes the isolation of an ACE inhibitory phosphopeptides having
antihypertensive effect from Oyster, Crassostrea gigas.
To investigate the resistance of phosphoprotein to digestion by gastrointestinal pro-
teases, phosphoprotein was digested by various proteases: pepsin, trypsin, chymotrypsin.
In this study, in the case of peptic hydrolysates of oyster contained two major ACE
inhibitors (P-l and P-2) that were fractionated by gel filtration. The specific activity for
ACE inhibition of the P-1 fraction was about 10 times higher than that of the P-2 fraction.
In the case of tryptic hydrolysates contained two major ACE inhibitors (T-l and
T--2) that were fractionated by gel filtation. The specific activity for ACE inhibition of the
T-l fraction was almost the same that of the T-2 fraction.
In the case of chymotryptic hydrolysates contained two major ACE inhibitors (C-l
and (-2) that were fractionated by gel filtration. The specific activity for ACE inhibition
of the C 1 fraction was almost the same that of the C -2 fraction. The pepsin treated
fraction P-l had most inhibition activity and showed O. 3mg protein/ml inhibition against
ACE at ICso value.
In previous papers];i ~ 17), author et. al. have reported that the inhibitory activity of
ACE detected in several shellfishes was fractionated into two major fractions of high
molecular weight and low molecular weight by gel filtration chromatography on Sephadex
G-50.
On the other hand, Sugiyama et. a}22) have already reported that the ACE inhibitory
activity of the alkaline protease hydrolysate from defatted sardine meal was reduced by
40% after a digestion test with gastrointestinal proteases.
Matsuda et.al,23) and Ogihira et.al. 241 have reported that di-and tri·peptides would
have low susceptibility to hydrolysis by any digestive enzymes.
Matsufuji et. al. 7) and Matsui et. al. 6) have reported that the ACE inhibitor isolated
from alkaline protease hydrolysate of sardine muscle was inhibited ACE competitively.
Kinoshita et. al. 11) have reported that the inhibitory activity of ACE detected in soy
sause was fractionated into two major fractions high molecular weight (HW) and low
molecular weight (LW) by gel filtration chromatography on Bio~gel P-2; the HW fraction
reduced the blood pressure in hypertensive rats after orally administering, while the LW
fraction did not.
On the other hand, the search related to the structure and function of phos-
phonomacromolecules will be one of the most facinating fields. Aminophosphonic acid are
present in various bound forms other than the phosphonolipids and antibiotic
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tripeptides. For instant, 2 - AEP is found in Tetrahymena associated with macromolecular
complexes which resist hydrolysis by proteolytic enzymes such as protease and tryp-
sin2:i) •
Gibson and Dixon26 ) isolated from the sea anemone Metridium senile three
chymotrypsin-like protease, of which two were proved by Stevenson et. al. 27) to contain
2 - AEP. The two enzymes, protease A and B, have properties similar to the mammalian
r- chymotrypsin with respect to the active--site amino acid sequence and the mode of
enzyme action.
Protease A contained 6 2 - AEP residues per 243 residues of total amino acids and
protease B had 4 2 - AEP residues per 239 residues of total amino acids.
The site of attachment of the 2 --- AEP to three proteases are yet unknown. Quin28l
purified a polypeptide containing 4.4% 2 - AEP by pepsin hydrolysis of the insoluble
residue from alcohol and chloroform extracts of M dianthus, and found that none of the
2 - AEP with the amino group free was present.
From the results above, it has been demonstrated that the isolated peptide inhibitors
occurs as the phosphonate containing phosphonopeptides and phosphate containing
phosphopeptides, but more experiments will be needed to prove the ACE inhibition of the
phosphopeptides isolated from oyster.
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